Results
|
|
2881.
|
|
|
|
2882.
|
|
|
|
2883.
|
|
|
|
2884.
|
|
|
|
2885.
|
|
|
|
2886.
|
|
|
|
2887.
|
|
|
|
2888.
|
|
|
|
2889.
|
|
|
|
2890.
|
|
|
|
2891.
|
|
|
|
2892.
|
|
|
|
2893.
|
Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules. [electronic resource] by
- Advani, Ranjana H
- Hurwitz, Herbert I
- Gordon, Michael S
- Ebbinghaus, Scot W
- Mendelson, David S
- Wakelee, Heather A
- Hoch, Ute
- Silverman, Jeffrey A
- Havrilla, Nancy A
- Berman, Craig J
- Fox, Judith A
- Allen, Roberta S
- Adelman, Daniel C
Producer: 20100806
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16
Availability: No items available.
|
|
|
2894.
|
|
|
|
2895.
|
|
|
|
2896.
|
|
|
|
2897.
|
A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies. [electronic resource] by
- Cirkel, Geert A
- Kerklaan, Bojana Milojkovic
- Vanhoutte, Frédéric
- Van der Aa, Annegret
- Lorenzon, Giocondo
- Namour, Florence
- Pujuguet, Philippe
- Darquenne, Sophie
- de Vos, Filip Y F
- Snijders, Tom J
- Voest, Emile E
- Schellens, Jan H M
- Lolkema, Martijn P
Producer: 20161213
In:
Investigational new drugs vol. 34
Availability: No items available.
|
|
|
2898.
|
|
|
|
2899.
|
|
|
|
2900.
|
|